Show simple item record

dc.contributor.authorKılıçkap, Sadettin
dc.contributor.authorÖztürk, Akın
dc.contributor.authorKaradurmuş, Nuri
dc.contributor.authorKorkmaz, Taner
dc.contributor.authorYumuk, Perran Fulden
dc.contributor.authorÇiçin, İrfan
dc.contributor.authorPaydaş, Semra
dc.contributor.authorÇılbır, Ebru
dc.contributor.authorSakalar, Teoman
dc.contributor.authorUysal, Mükremin
dc.contributor.authorÜskent, Necdet
dc.contributor.authorDemir, Nurcan
dc.contributor.authorSakin, Ayşegül
dc.contributor.authorTurhal, Nazım Serdar
dc.contributor.authorKeskin, Serhat
dc.contributor.authorTural, Deniz
dc.contributor.authorEralp, Yeşim
dc.contributor.authorBuğdaycı Başal, Fatma
dc.contributor.authorYaşar, Hatime Arzu
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.contributor.authorDemirci, Umut
dc.contributor.authorÇubukçu, Erdem
dc.contributor.authorKaraağaç, Mustafa
dc.contributor.authorKaraca, Saziye
dc.contributor.authorTatlı, Ali Murat
dc.contributor.authorYetişyiğit, Tarkan
dc.contributor.authorUrvay, Semiha
dc.contributor.authorGürsoy, Pınar
dc.contributor.authorOyan Uluç, Başak
dc.contributor.authorTurna, Zeynep Hande
dc.contributor.authorKüçüköner, Mehmet
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorÇabuk, Devrim
dc.contributor.authorŞeker, Mesut
dc.contributor.authorÜnal, Olçun Umut
dc.contributor.authorMeydan, Nezih
dc.contributor.authorOkutur, Sadi Kerem
dc.contributor.authorTunalı, Duygu
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:50:06Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:50:06Z
dc.date.issued2018en_US
dc.identifier.citationKılıçkap, S., Öztürk, A., Karadurmuş, N., Korkmaz, T., Yumuk, P., Çiçin, İ. ... Tunalı, D. (2018). Crizotinib efficacy in alk-positive advanced stage non-small cell lung cancer patients: A real-world experience from Turkey. Journal of Thoracic Oncology içinde (S477-S478. ss.).en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1881
dc.descriptionWOS: 000454014501235en_US
dc.description.abstractBackground: Increasing evidence leads to a ratiocination that genetic heterogeneity of the lung adenocarcinoma patients with sensitive EGFR mutations may impact clinical responses and outcomes to EGFR-TKIs. Method: We performed targeted NGS with a gene panel covering 416 cancer-related genes to profile genetic characteristics of 69 lung adenocarcinoma patients with activating EGFR mutations and assessed the contribution of targeted NGS to exploration of genetic heterogeneity of such cohort. Result: We detected total 200 actionable genetic alterations (mean 2.9 variations per patient, range: 1-7 variations) in tumor DNA and 140 actionable genetic alterations (mean 2.0 variations per patient, range: 0-5 variations) in matched plasma ctDNA, respectively. The concurrent genes with the highest mutation rate were TP53 (observed in 72.5% patients), other uncommon EGFR mutations (observed in 21.7% patients), EGFR amplification (observed in 20.3% patients), RB1 (observed in 10.1% patients), PIK3CA (observed in 7.2% patients), and MYC (observed in 5.8% patients). NGS provides EGFR mutation detection in plasma with a test sensitivity of 88.2% and specificity of 100.0%.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNSCLCen_US
dc.subjectALK Inhibitoren_US
dc.subjectCrizotiniben_US
dc.titleCrizotinib efficacy in alk-positive advanced stage non-small cell lung cancer patients: A real-world experience from Turkeyen_US
dc.typeconferenceObjecten_US
dc.relation.ispartofJournal of Thoracic Oncologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume13en_US
dc.identifier.issue10en_US
dc.identifier.startpageS477en_US
dc.identifier.endpageS478en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.wosqualityQ1en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record